tiprankstipranks
Trending News
More News >
inTEST Corporation (INTT)
:INTT

inTEST (INTT) AI Stock Analysis

Compare
269 Followers

Top Page

INTT

inTEST

(INTT)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 5.2)
Rating:65Neutral
Price Target:
$12.50
▲(7.30% Upside)
Action:ReiteratedDate:02/28/26
The score is driven by mixed financial performance (losses and weaker free cash flow offset by a strong balance sheet and positive cash generation) and a constructive earnings outlook with improving margins and backlog. Technicals are supportive but overbought, while valuation is constrained by negative earnings and no indicated dividend support.
Positive Factors
Conservative Balance Sheet
A modest debt-to-equity (~0.18 TTM) and sizable equity position give inTEST durable financial flexibility. This conservative capital structure supports funding product development, working capital and strategic initiatives through cycles without immediate reliance on dilutive financing.
Positive Cash Generation
inTEST generates positive operating and free cash flow despite a TTM net loss, and free cash flow is close in magnitude to net income. Sustained positive cash generation underpins debt reduction, modest capex, and working capital needs, improving resilience over the medium term.
Diversification & Backlog Visibility
Meaningful revenue diversification (≈80% non-semiconductor in Q4), accelerating new-product traction, and a growing backlog ($53.9M, +36% YoY) provide multi-quarter to multi-year revenue visibility and reduce reliance on a single cyclical market, supporting more stable medium-term growth.
Negative Factors
Profitability Deterioration
A return to net loss and a sharp EBITDA margin contraction materially weaken earnings quality and return metrics. Sustained profitability erosion makes it harder to fund growth internally and undermines long-term shareholder returns unless margin recovery and scale gains are achieved.
Revenue Decline & Semi Exposure
A sizable revenue decline driven largely by semiconductor weakness highlights cyclicality and end-market sensitivity. Until non-semiconductor diversification and new-product adoption scale sufficiently, aggregate revenue remains exposed to uneven demand in semiconductors and broader capital-spending cycles.
Past Covenant Pressure
Reliance on a loan waiver and conditional covenant compliance indicates past financial strain and creates execution risk. If operational improvement lags, access to committed facilities or covenant compliance could constrain liquidity and strategic choices over the medium term.

inTEST (INTT) vs. SPDR S&P 500 ETF (SPY)

inTEST Business Overview & Revenue Model

Company DescriptioninTEST Corporation supplies test and process solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through two segments, Thermal Products (Thermal) and Electromechanical Semiconductor Products (EMS). The Thermal segment offers ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; Thermal Chambers; Thermal Platforms; Thermonics temperature conditioning products that provide tempered gas or fluid; ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions; EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The EMS segment provides in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly or the handler's test socket. This segment also offers tester interfaces that provide electrical connections between the tester and the wafer prober or integrated circuit (IC) handler; and scorpion flying probe test systems, which designs and manufactures robotics-based electronic test equipment, as well as provides application support services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.
How the Company Makes MoneyinTEST generates revenue through the sale of its core products and services, which include test and measurement equipment, temperature management systems, and automated test solutions. The company earns income from both direct sales and through long-term contracts with semiconductor manufacturers and electronics companies. Key revenue streams include product sales, service agreements, and maintenance contracts. Additionally, inTEST may benefit from partnerships with other technology firms, which can enhance its product offerings and expand its market reach, further contributing to its earnings.

inTEST Earnings Call Summary

Earnings Call Date:Feb 27, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 01, 2026
Earnings Call Sentiment Positive
The call conveys cautious optimism: a strong Q4 rebound with order momentum, expanding backlog, margin improvement, meaningful diversification away from semiconductors, and a constructive 2026 guide all point to recovery and improved profitability prospects. However, material 2025 year-over-year declines in revenue and profitability driven largely by semiconductor weakness, a modest semi recovery assumed in guidance, past covenant relief, and certain one-time items temper near-term visibility and present risks if macro or semiconductor demand does not strengthen as expected.
Q4-2025 Updates
Positive Updates
Strong Q4 Revenue Beat and Sequential Recovery
Q4 revenue of $32.8M, above guidance and the highest quarter of the year; Q4 revenue rose $6.6M or 25% sequentially from $26.2M in Q3 (including ~$2M of shipments slipped from Q3).
Robust Order Momentum and Growing Backlog
Q4 orders exceeded $37M and Q4 orders were up 22% year-over-year (+$0.8M vs Q4 2024). Year-end backlog $53.9M, up 36% year-over-year and 9% sequentially; ~60% of backlog expected to ship beyond 2026, providing forward visibility.
Gross Margin Expansion
Q4 gross margin expanded to 45.4%, up 350 basis points sequentially and 570 basis points year-over-year, driven by volume gains and higher sales of higher-margin new Alphamation products; full-year normalized gross margin ~43%.
Profitability Improvement in Q4 Metrics
Q4 net income $1.2M; adjusted EBITDA $3.2M representing a 9.7% adjusted EBITDA margin versus a Q3 trough of $0.4M (1.5%); Q4 diluted EPS $0.10, adjusted EPS $0.16.
Meaningful Market Diversification and New Product Traction
Nearly 80% of Q4 revenue derived from non-semiconductor end markets; life sciences orders tripled sequentially in Q4 and full-year orders: life sciences +137% YoY, auto EV +89% YoY, industrial +53% YoY. New product contributions (Alphamation, Archaeologic) accelerating progress toward Vision 2030 target of 25% revenue from new products.
Debt Reduction and Strong Liquidity Position
Reduced debt by $1.4M in Q4 and $7.6M in 2025 to total debt of $7.5M; liquidity approximately $58M including $18.1M cash and full access to a $30M delayed draw term loan facility and $10M revolver.
Prudent 2026 Guidance with Return-to-Growth Plan
Provided 2026 guidance: revenue $125M–$130M (midpoint ~12% growth vs 2025), gross margin ~45%, operating expenses $53M–$55M, Q1 revenue guide $31M–$33M and Q1 gross margin ~44%; management expects a year of returning growth while not assuming a major semi rebound.
Operational Efficiency and Cost Discipline
Manufacturing efficiency initiatives, scaling of Malaysia operations, and cost actions helped reduce operating expenses as a percent of revenue to 41.5% in Q4 and contributed to margin lift despite low semi contribution.
Negative Updates
Full-Year Profitability Decline
Full-year 2025 net loss of $2.5M; full-year adjusted EBITDA $4.0M (3.5% adjusted EBITDA margin) versus $10.8M and an 8.3% margin in 2024, indicating material year-over-year profitability deterioration.
Revenue Decline Year-over-Year Driven by Semiconductor Weakness
2025 revenue declined roughly $17M versus 2024, with about three quarters of that decline attributable to semiconductor market weakness; Q4 revenue was down $3.8M versus Q4 2024, and semi revenue declined $2.9M sequentially in Q4.
Ongoing Semi Market Softness and Modest Semi Guidance
Semi remains soft: semi represented ~25% of Q4 orders vs 40% in 2024. Management baked only a modest semi recovery into 2026 guidance and did not assume a meaningful rebound, leaving exposure to semiconductor demand timing risk.
Earnings Per Share Compression
Full-year adjusted net income $0.8M or $0.06 adjusted EPS for 2025 versus adjusted EPS of $0.51 in 2024 — a substantial decline in adjusted per-share profitability.
Operating Expense Pressures and One-Time Items
Q4 operating expenses increased $1.4M sequentially to $13.6M (driven by higher sales commissions and marketing). Comparisons also impacted by nonrecurring items: Q4 2024 had an $800k amortization credit and Q4 2025 included $200k of restructuring charges, complicating year-over-year comparability.
Term Loan Covenant Waiver and Compliance Timeline
Company operated under a waiver on its term loan entered in August; management expects to return to full covenant compliance by midyear, indicating past covenant pressure and a conditional liquidity position until compliance is restored.
Concentration of Backlog Shipping Beyond 2026
Approximately 60% of backlog is expected to ship beyond 2026. While this provides multi-year visibility, it also means a significant portion of revenue is not near-term and could delay revenue recognition if customer plans shift.
Full-Year Capital Spending Shortfall in Non-Semiconductor Markets
Management noted that the remainder of the revenue decline (beyond semiconductor weakness) reflected a slower-than-anticipated capital spending recovery in non-semiconductor end markets, signaling broader macro sensitivity in demand.
Company Guidance
Management guided Q1 2026 revenue of $31–33M with gross margin of ~44%, operating expenses of $13.3–13.7M and $0.8M of amortization; for full-year 2026 they forecast $125–130M revenue (≈12% growth at the midpoint vs $113.8M in 2025), ~45% gross margin, operating expenses of $53–55M, $2.6M of amortization, approximately $300k of interest expense, an ~18% effective tax rate, and capex of 1–2% of revenue. The guidance assumes no material tariff or geopolitical impact, does not rely on a meaningful semiconductor rebound, expects Q1 margin to be below Q4 due to product/customer mix with higher amortization in H1, anticipates returning to loan‑covenant compliance by midyear, and reflects the company’s strong liquidity position (≈$18.1M cash, ~$58M total liquidity), $7.5M debt outstanding and full access to a $30M delayed‑draw facility plus a $10M revolver.

inTEST Financial Statement Overview

Summary
Mixed fundamentals: profitability deteriorated TTM with revenue contraction and a return to losses (weak income statement), but the balance sheet is conservatively levered and cash flow remains positive despite a sharp free-cash-flow decline versus the prior year.
Income Statement
52
Neutral
Profitability has weakened materially versus prior years. TTM (Trailing-Twelve-Months) revenue declined (-3.2%) and the company moved back to losses (negative net margin and negative operating margin), following solid profitability in 2023–2024. Gross margin remains healthy (~41% TTM) but is down from the mid-to-high 40% range earlier in the period, indicating some pressure on pricing and/or costs. Overall, earnings quality looks cyclical and currently in a downswing despite still-strong gross profit generation.
Balance Sheet
74
Positive
The balance sheet is a relative strength. Leverage is modest with low debt versus equity (debt-to-equity ~0.18 TTM), and equity is sizable relative to total assets. However, returns have turned negative TTM (negative return on equity) due to the earnings decline, which is the key weakness. In sum: financially stable capital structure, but near-term profitability is not supporting returns.
Cash Flow
63
Positive
Cash generation is positive in TTM (Trailing-Twelve-Months), with operating cash flow and free cash flow both solidly positive, which helps offset the current net loss. That said, free cash flow fell sharply versus the prior year (down ~41% TTM), pointing to weaker underlying cash momentum. Cash conversion vs. earnings is supportive (free cash flow is close in magnitude to net income despite a loss), but the recent step-down in free cash flow is a notable risk if the downturn persists.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue113.83M130.69M123.30M116.83M84.88M
Gross Profit48.92M55.42M56.98M53.44M41.22M
EBITDA4.02M9.74M16.41M15.51M11.64M
Net Income-2.53M2.89M9.34M8.46M7.28M
Balance Sheet
Total Assets151.31M152.29M134.83M110.07M103.91M
Cash, Cash Equivalents and Short-Term Investments14.22M19.83M45.26M13.43M21.20M
Total Debt15.56M26.04M17.46M22.49M26.72M
Total Liabilities47.69M52.50M38.55M45.11M49.08M
Stockholders Equity103.62M99.79M96.28M64.96M54.82M
Cash Flow
Free Cash Flow5.68M2.50M14.91M-2.75M9.85M
Operating Cash Flow7.32M3.82M16.20M-1.39M10.84M
Investing Cash Flow-1.63M-20.05M-1.29M-1.17M-21.37M
Financing Cash Flow-8.22M-8.64M15.61M-3.73M21.73M

inTEST Technical Analysis

Technical Analysis Sentiment
Positive
Last Price11.65
Price Trends
50DMA
8.89
Positive
100DMA
8.46
Positive
200DMA
7.78
Positive
Market Momentum
MACD
0.45
Negative
RSI
72.28
Negative
STOCH
70.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For INTT, the sentiment is Positive. The current price of 11.65 is above the 20-day moving average (MA) of 10.06, above the 50-day MA of 8.89, and above the 200-day MA of 7.78, indicating a bullish trend. The MACD of 0.45 indicates Negative momentum. The RSI at 72.28 is Negative, neither overbought nor oversold. The STOCH value of 70.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INTT.

inTEST Risk Analysis

inTEST disclosed 3 risk factors in its most recent earnings report. inTEST reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

inTEST Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$145.43M-56.01-2.24%-2.20%-204.45%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
$188.00M-44.72%-21.59%-254.69%
55
Neutral
$1.42B-18.99-9.04%-4.50%-45.79%
54
Neutral
$1.15B-126.67-6.97%-3.23%-122.16%
50
Neutral
$98.95M-2.65-8.46%-7.79%10.04%
49
Neutral
$39.96M-1.35-38.72%16.01%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
INTT
inTEST
11.65
3.50
42.94%
AEHR
Aehr Test Systems
37.43
28.58
322.94%
ASYS
Amtech Systems
13.05
8.09
163.10%
COHU
Cohu
30.20
12.43
69.95%
MX
MagnaChip
2.75
-1.63
-37.21%
PXLW
Pixelworks
6.35
-1.93
-23.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 28, 2026